| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/30/2004 | US20040265898 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 12/30/2004 | US20040265896 pharmacogenetics; determining if patient has said variant which causes sensitivity to ivermectin and other drugs that serve as P-glycoprotein substrates; canine cell used for studying effect of various drugs |
| 12/30/2004 | US20040265895 assaying for an A908G mutation in an estrogen receptor alpha nucleic acid sequence, a diagnostic marker; kits |
| 12/30/2004 | US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis |
| 12/30/2004 | US20040265889 biomarker polypeptides for determining if a test substance will cause hepatotoxicity; kits |
| 12/30/2004 | US20040265888 Binary encoded sequence tags |
| 12/30/2004 | US20040265887 predicting a clinical response to treatment with a chemotherapeutic agent by determining the activity of a gene encoding a DNA repair enzyme |
| 12/30/2004 | US20040265885 Peptide nucleic acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone; can be purified using efficient methods such as chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 12/30/2004 | US20040265877 Methods for detecting presence of cellular constituents |
| 12/30/2004 | US20040265874 Pattern recognition method for diagnosis of systemic autoimmune diseases |
| 12/30/2004 | US20040265872 nucleotide sequences for polypeptides of the riboflavin specific deaminase family, "ribG"; drug target for use screening for antibacterials; vectors, host cells |
| 12/30/2004 | US20040265866 Receptor on the surface of activated T-cells: ACT-4 |
| 12/30/2004 | US20040265865 Method for identifying effector molecules |
| 12/30/2004 | US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy |
| 12/30/2004 | US20040265851 Polymerase chain reaction to quantify pyrophosphoric acid production; analyzing actin and/or glyceraldehyde 3-phosphate dehydrogenase levels |
| 12/30/2004 | US20040265849 Point mutation analysis of glyceraldehyde-3-phosphate dehydrogenase genes via allele-specific probe hybridization and/or nuclease digestion; kits; drug screening |
| 12/30/2004 | US20040265847 Administering zinc binding agent (sodium citrate) to modulate interaction within central nervous system between zinc and/or heparin with amyloid precursor proteins |
| 12/30/2004 | US20040265845 Amplifying nucleic acid targets from panels containing markers such as antigens, binding proteins, and/or tyrosinase; reverse transcriptase-polymerase chain reaction (RT-PCR); kits |
| 12/30/2004 | US20040265844 Integrated high throughput system for the analysis of biomolecules |
| 12/30/2004 | US20040265843 Integrated high throughput system for the analysis of biomolecules |
| 12/30/2004 | US20040265841 Analyzing mutations in Myosin Light Chain 2a; titin-related diseases; drug screening; animal models; knockout cells; transgenic zebrafish; antibodies |
| 12/30/2004 | US20040265840 Preservation of RNA quality and content in tissue sections during immunohistochemistry |
| 12/30/2004 | US20040265837 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 12/30/2004 | US20040265829 Identification of genes involved in restenosis and in atherosclerosis |
| 12/30/2004 | US20040265826 Method for sequencing nucleic acids |
| 12/30/2004 | US20040265825 Methods and compositions for diagnosing and treating a subject having depression |
| 12/30/2004 | US20040265824 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 12/30/2004 | US20040265822 Method of detecting, identifying and counting enteritis vibrio using gene (rpod) sequences encoding rna polymerase sigma 70 factor |
| 12/30/2004 | US20040265819 Uricosuric regulating action using protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom being capable of transporting uric acid and its analogs; cardiovascular disorders; gout; hypotensive agents; nucleotide sequences; antibodies; modulators |
| 12/30/2004 | US20040265818 Histidine phosphatase interacting protein with 180kd |
| 12/30/2004 | US20040265817 Method of selecting substance characterized by assaying ppard activating effect and drug |
| 12/30/2004 | US20040265810 Contacting with a solid support coupled to a chemical comprising a cleavable functional group; mass spectrometry tag which transfers to the polypeptide upon cleavage; allows quantitative analysis of complex mixtures of analytes |
| 12/30/2004 | US20040265809 Polypeptides derived from retinoic acid-related orphan receptor(ror) and their applications |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265804 Method for identifying metastatic tumor cells |
| 12/30/2004 | US20040265801 Immunoassays for anti-HCV antibodies |
| 12/30/2004 | US20040265800 Sample pretreatment solution for immunological test and method for using the same |
| 12/30/2004 | US20040265795 staining with a fluorochromic or fluorogenic substance which binds to the cholesterol-containing envelope and quantitatively determining the fluorescence signals of the individual particles under a fluorescence microscope |
| 12/30/2004 | US20040265794 Genotyping kit for diagnosis of human papilloma virus infection |
| 12/30/2004 | US20040265793 Diabetic model |
| 12/30/2004 | US20040265792 Agents for treatment of hcv and methods of use |
| 12/30/2004 | US20040265791 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 12/30/2004 | US20040265790 Methods and compositions for modulating T lymphocytes |
| 12/30/2004 | US20040265789 screening for herbicides by determining if a test compound binds to 3-oxo-5-alpha-steroid 4-dehydrogenase (DET2); binding compounds are potential herbicides; DET2 is essential enzyme for plant growth |
| 12/30/2004 | US20040265788 Screen for sodium channel modulators |
| 12/30/2004 | US20040265787 Immortalized human keratinocyte cell line |
| 12/30/2004 | US20040265476 Methods for producing ligand arrays |
| 12/30/2004 | US20040265440 Food borne pathogen sensor and method |
| 12/30/2004 | US20040265386 Gel compositions |
| 12/30/2004 | US20040265332 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 12/30/2004 | US20040265331 BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 12/30/2004 | US20040265330 Novel compounds |
| 12/30/2004 | US20040265328 Identifying polypeptide antigens that bind to sera raised against commensal bacterial proteins |
| 12/30/2004 | US20040265326 Culturing respiratory syncytial virus on cells in a culture medium; separating grown virus from culture medium; solubilizing at least fusion (F) protein, attachment (G) protein and matrix (M) protein from the separated virus; coisolating ,copurifying solubilized RSV proteins; immunogenic |
| 12/30/2004 | US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid |
| 12/30/2004 | US20040265314 Soluble CLCA-1 and antagonists to CLCA-1 |
| 12/30/2004 | US20040265311 Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity |
| 12/30/2004 | US20040265308 Prevention and treatment of amyloidogenic disease |
| 12/30/2004 | US20040265307 Anti-IGF-I receptor antibody |
| 12/30/2004 | US20040265303 Anti-CCR2 antibodies and methods of use therefor |
| 12/30/2004 | US20040265302 Preventing airway mucus production by administration of EGF-R antagonists |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040265287 Myocardial grafts and cellular compositions useful for same |
| 12/30/2004 | US20040265281 System capable of treating and defining various diseases using stem cells |
| 12/30/2004 | US20040265252 trisubstituted triazines and agents that interact with prohibitin or mitochondrial ATPase to determine if the test compound inhibits or stimulates pigmentation; self-tanning; substituents are fluorophenoxy- and fluorobenzylamino- and a TRIETHYLENE GLYCOL DIAMINo- |
| 12/30/2004 | US20040265234 native and/or denatured food allergens recognized by IgE antibodies of food-allergy patients, antibodies prepared by immunizing an animal with the mixture and a method for detecting the food allergens and allergy-inducing foods that involves using said antibodies |
| 12/30/2004 | US20040265233 incorporated in a polysiloxane matrix having functional groups; suitable for magnetic separation |
| 12/30/2004 | US20040265230 Compositions and methods for diagnosing and treating colon cancers |
| 12/30/2004 | US20040265229 Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| 12/30/2004 | US20040265209 reacting the single-wall carbon nanotubes with a compound that provides at least one substituent, such as peptides or amino acids |
| 12/30/2004 | US20040265181 Method and apparatus for manufacturing beads array chip |
| 12/30/2004 | US20040265177 Stability assessment of dispersions and emulsions |
| 12/30/2004 | US20040265176 comprises a tank, feeders, extractors, analyzer; extractors comprise an ultrasonic electroacoustic transducer and the mud feeders comprise volume and flow rate regulators that enable a preset constant volume of mud to be guaranteed in the tank and the flow rate to be adjusted to a preset constant value |
| 12/30/2004 | US20040265175 Apparatus and method for process monitoring |
| 12/30/2004 | US20040265171 Method for uniform application of fluid into a reactive reagent area |
| 12/30/2004 | US20040265169 Inspection tester for explosives |
| 12/30/2004 | US20040263923 Hybrid random bead/chip based microarray |
| 12/30/2004 | US20040263851 Active remote sensing using a simultaneous spectral sampling technique |
| 12/30/2004 | US20040263543 Production method and production apparatus of probe carrier |
| 12/30/2004 | US20040263187 Oil deterioration sensor |
| 12/30/2004 | US20040262585 Use of dendrimers and poly-branched molecules to enhance signal in fluorescent assay systems |
| 12/30/2004 | US20040262524 Multi-energy gamma attenuation for real time continuous measurement of bulk material |
| 12/30/2004 | US20040261500 Method and apparatus for sensing hydrogen gas |
| 12/30/2004 | US20040261497 Determination of effective composition of a mixture of hydrocarbon gases |
| 12/30/2004 | US20040261495 Method and apparatus for determining the amount of gas contained in a liquid |
| 12/30/2004 | DE19963198B4 Verfahren zum topographischen Proteinnachweis an formalinfixierten Gewebeschnitten A method for topographic protein detection in formalin-fixed tissue sections |
| 12/30/2004 | DE19846487C5 Meßsonde für die Detektion der Momentankonzentrationen mehrerer Gasbestandteile eines Gases Probe for detecting the instantaneous concentrations of a plurality of gas constituents of a gas |
| 12/30/2004 | DE10326586A1 Verfahren zur Messung und zur Kontrolle der Biofilmbildung in einem Wassersystem A method for measuring and controlling biofilm formation in a water system |
| 12/30/2004 | DE10325173A1 Nachweisverfahren für Fibrinogen und/oder Fibrinogen-Derivate Detection methods for fibrinogen and / or fibrinogen derivatives |
| 12/30/2004 | DE10324447A1 Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin Generation of artificial binding proteins on the basis of ubiquitin |
| 12/30/2004 | DE10323441A1 Vorrichtung zum Fördern eines Fluidvolumens, Gerät und Verfahren zur Analyse desselben Of the same apparatus for conveying a volume of fluid, the device and method for analyzing |
| 12/30/2004 | DE10235182B4 Verfahren zur Herstellung von Nanopartikeln Process for the preparation of nanoparticles |
| 12/30/2004 | DE102004023425A1 Verfahren zur Feststellung der Cu-Konzentration eines Siliciumsubstrats Method for the determination of Cu concentration of a silicon substrate |
| 12/30/2004 | CA2470889A1 Method for classifying plant embryos using raman spectroscopy |
| 12/30/2004 | CA2469140A1 Hcv regulated proteins |
| 12/29/2004 | WO2004114195A1 Predictive toxicology for biological systems |
| 12/29/2004 | WO2004114191A2 Method and apparatus for object based biological information, manipulation and management |
| 12/29/2004 | WO2004114081A2 Methods and systems for creation of a coherence database |
| 12/29/2004 | WO2004113950A1 Method and apparatus for monitoring and measuring oil spills |
| 12/29/2004 | WO2004113926A2 Diagnosis of pre-eclampsia |